Literature DB >> 6684569

Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.

A Koenders, S M Thorpe.   

Abstract

Four different lyophilized cytosols were analyzed for estrogen and progesterone receptor content by 13 laboratories. Three of the cytosols were assayed on 9 consecutive working days. The fourth cytosol was analyzed 3 times. All laboratories used the same methods of receptor and protein assays. Estradiol and progesterone receptors were measured by Scatchard analysis with centrally provided radioactive ligands and employing charcoal adsorption of free steroid. Protein was assayed by the Bradford technique with the same lots of Coomassie brilliant blue and human serum albumin standard. All participating groups except one produced receptor results (fmol/ml cytosol) with less inter-laboratory variation than in previous trials. Recalculation of the raw data of all participants by a common computer program further reduced this inter-laboratory variation. The discrepancies between the reported and recalculated receptor binding data are discussed. The intra-laboratory variation was sometimes surprisingly high and occurred at random. Single-dose saturation assays showed good agreement with multipoint Scatchard assays for the high receptor-positive samples, while poor agreement was observed for the heat-inactivated, receptor-negative sample. The use of common reagents and methodologies diminished the inter-laboratory variation coefficients of the protein assay to 14-17%; however, the protein estimation still needs to be improved.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684569     DOI: 10.1016/0277-5379(83)90199-2

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  6 in total

1.  Improvement of quality control for steroid receptor measurements: analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular Biopathology.

Authors:  S Romain; F Spyratos; J Goussard; J L Formento; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays.

Authors:  S M Thorpe
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

3.  Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.

Authors:  C Rose; H T Mouridsen; S M Thorpe; J Andersen; M Blichert-Toft; K W Andersen
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

4.  Comparison of ligand binding assay and enzyme immunoassay of oestrogen receptor in human breast cancer cytosols. Experience of the E.O.R.T.C. Receptor Group.

Authors:  M A Blankenstein
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

5.  Steroid hormone receptors in human salivary gland tumours.

Authors:  P J Lamey; R E Leake; S K Cowan; D S Soutar; I A McGregor; F M McGregor
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

6.  Stability of oestrogen receptor status in sequential biopsies from patients with breast cancer.

Authors:  D J Crawford; S Cowan; R Fitch; D C Smith; R E Leake
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.